PMID-sentid	Pub_year	Sent_text	compound_name	comp_offset	prot_official_name	organism	prot_offset
32760206-7	2020	The drugs triciribine and kinetin riboside activate ACE2 expression or inhibit IL-6 production in macrophages to some extent.	kinetin riboside	26-42	angiotensin converting enzyme 2	Homo sapiens	52-56
32760206-7	2020	The drugs triciribine and kinetin riboside activate ACE2 expression or inhibit IL-6 production in macrophages to some extent.	kinetin riboside	26-42	interleukin 6	Homo sapiens	79-83
18431519-0	2008	Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity.	kinetin riboside	18-34	cyclin D1	Homo sapiens	53-58
28323427-0	2017	Kinetin Riboside and Its ProTides Activate the Parkinson"s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization.	kinetin riboside	0-16	PTEN induced kinase 1	Homo sapiens	78-108
28323427-0	2017	Kinetin Riboside and Its ProTides Activate the Parkinson"s Disease Associated PTEN-Induced Putative Kinase 1 (PINK1) Independent of Mitochondrial Depolarization.	kinetin riboside	0-16	PTEN induced kinase 1	Homo sapiens	110-115
28323427-3	2017	These ProTides, along with kinetin riboside, activated PINK1 in cells independent of mitochondrial depolarization.	kinetin riboside	27-43	PTEN induced kinase 1	Homo sapiens	55-60
20139069-7	2010	We showed that the overexpression of FKBP38 attenuates reduction rate of Bcl-2, thus resulting in an increment of the intracellular Bcl-2 level, contributing to the resistance of apoptotic cell death induced by the treatment of kinetin riboside, an anticancer drug.	kinetin riboside	228-244	FKBP prolyl isomerase 8	Homo sapiens	37-43
20139069-7	2010	We showed that the overexpression of FKBP38 attenuates reduction rate of Bcl-2, thus resulting in an increment of the intracellular Bcl-2 level, contributing to the resistance of apoptotic cell death induced by the treatment of kinetin riboside, an anticancer drug.	kinetin riboside	228-244	BCL2 apoptosis regulator	Homo sapiens	73-78
20139069-7	2010	We showed that the overexpression of FKBP38 attenuates reduction rate of Bcl-2, thus resulting in an increment of the intracellular Bcl-2 level, contributing to the resistance of apoptotic cell death induced by the treatment of kinetin riboside, an anticancer drug.	kinetin riboside	228-244	BCL2 apoptosis regulator	Homo sapiens	132-137
19186174-0	2009	The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines.	kinetin riboside	34-54	cyclin dependent kinase inhibitor 1A	Homo sapiens	125-131
19186174-0	2009	The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines.	kinetin riboside	34-54	cyclin dependent kinase inhibitor 1A	Homo sapiens	132-135
19186174-0	2009	The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines.	kinetin riboside	56-72	cyclin dependent kinase inhibitor 1A	Homo sapiens	125-131
19186174-0	2009	The experimental chemotherapeutic N6-furfuryladenosine (kinetin-riboside) induces rapid ATP depletion, genotoxic stress, and CDKN1A(p21) upregulation in human cancer cell lines.	kinetin riboside	56-72	cyclin dependent kinase inhibitor 1A	Homo sapiens	132-135
18431519-0	2008	Identification of kinetin riboside as a repressor of CCND1 and CCND2 with preclinical antimyeloma activity.	kinetin riboside	18-34	cyclin D2	Homo sapiens	63-68
18431519-5	2008	Kinetin riboside induced marked suppression of CCND2 transcription and rapidly suppressed cyclin D1 and D2 protein expression in primary myeloma cells and tumor lines, causing cell-cycle arrest, tumor cell-selective apoptosis, and inhibition of myeloma growth in xenografted mice.	kinetin riboside	0-16	cyclin D2	Mus musculus	47-52
18431519-5	2008	Kinetin riboside induced marked suppression of CCND2 transcription and rapidly suppressed cyclin D1 and D2 protein expression in primary myeloma cells and tumor lines, causing cell-cycle arrest, tumor cell-selective apoptosis, and inhibition of myeloma growth in xenografted mice.	kinetin riboside	0-16	cyclin D1	Mus musculus	90-99
18162289-0	2008	Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells.	kinetin riboside	0-16	B cell leukemia/lymphoma 2	Mus musculus	64-69
18162289-0	2008	Kinetin riboside preferentially induces apoptosis by modulating Bcl-2 family proteins and caspase-3 in cancer cells.	kinetin riboside	0-16	caspase 3	Mus musculus	90-99